Agarwal, A;
Agrawal, R;
Raje, D;
Testi, I;
Mahajan, S;
Gunasekeran, DV;
Aggarwal, K;
... Gupta, V; + view all
(2020)
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Ocular Immunology and Inflammation
10.1080/09273948.2020.1761401.
(In press).
Preview |
Text
Pavesio_COTS 1 24 month outcomes.pdf - Accepted Version Download (368kB) | Preview |
Abstract
Purpose To report the clinical findings, anatomical features, and treatment outcomes in subjects with ocular tuberculosis (OTB) at 24 months in the Collaborative Ocular Tuberculosis Study (COTS)-1. Methods Of the 945 subjects included in COTS-1, those who completed a 24-month follow-up after completion of treatment were included. The main outcome measure was a number of patients with treatment failure (TF). Results 228 subjects (120 males; mean age of 42.82 ± 14.73 years) were included. Most common phenotype of uveitis was posterior (n = 81; 35.53%), and panuveitis (n = 76; 33.33%). Fifty-two patients (22.81%) had TF. On univariable analysis, odds of high TF was observed with bilaterality (OR: 3.46, p = .003), vitreous haze (OR: 2.14, p = .018), and use of immunosuppressive therapies (OR: 5.45, p = .003). However, only bilaterality was significant in the multiple regression model (OR: 2.84; p = .02). Conclusions Majority of subjects (>75%) achieved cure in the COTS-1 at 24-month follow-up. The concept of “cure” may be a valuable clinical endpoint in trials for OTB.
Type: | Article |
---|---|
Title: | Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1080/09273948.2020.1761401 |
Publisher version: | https://doi.org/10.1080/09273948.2020.1761401 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Ocular tuberculosis, uveitis, antitubercular therapy, tuberculous, tubercular uveitis, cure, Collaborative Ocular Tuberculosis Study (COTS) group |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10116080 |
Archive Staff Only
View Item |